MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 35.728
AS - Asia 17.326
EU - Europa 11.205
SA - Sud America 1.692
Continente sconosciuto - Info sul continente non disponibili 1.222
AF - Africa 268
OC - Oceania 44
Totale 67.485
Nazione #
US - Stati Uniti d'America 35.229
HK - Hong Kong 5.774
SG - Singapore 4.823
IT - Italia 4.518
CN - Cina 2.749
UA - Ucraina 2.101
VN - Vietnam 1.471
BR - Brasile 1.195
DE - Germania 994
TR - Turchia 787
RU - Federazione Russa 683
IE - Irlanda 630
FR - Francia 621
KR - Corea 500
FI - Finlandia 496
SE - Svezia 479
IN - India 338
BD - Bangladesh 217
CA - Canada 209
GB - Regno Unito 207
AR - Argentina 202
IQ - Iraq 117
JP - Giappone 111
MX - Messico 110
EC - Ecuador 77
AT - Austria 67
ZA - Sudafrica 64
PL - Polonia 63
PK - Pakistan 61
ID - Indonesia 60
NL - Olanda 60
CO - Colombia 53
ES - Italia 52
VE - Venezuela 52
AU - Australia 35
EU - Europa 35
MA - Marocco 35
MY - Malesia 35
JM - Giamaica 34
CR - Costa Rica 32
UZ - Uzbekistan 32
PH - Filippine 31
CL - Cile 30
JO - Giordania 30
KE - Kenya 30
SA - Arabia Saudita 28
EG - Egitto 27
BE - Belgio 26
PE - Perù 25
PY - Paraguay 25
TN - Tunisia 24
CZ - Repubblica Ceca 21
IL - Israele 20
NO - Norvegia 18
NP - Nepal 18
CH - Svizzera 17
GT - Guatemala 17
RO - Romania 17
AE - Emirati Arabi Uniti 16
BG - Bulgaria 16
DZ - Algeria 16
HN - Honduras 16
LT - Lituania 15
UY - Uruguay 14
BO - Bolivia 13
ET - Etiopia 13
HU - Ungheria 11
PA - Panama 11
PT - Portogallo 11
RS - Serbia 11
SN - Senegal 11
SV - El Salvador 11
AL - Albania 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
GR - Grecia 9
HR - Croazia 9
LB - Libano 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
PS - Palestinian Territory 9
IR - Iran 8
KZ - Kazakistan 8
KG - Kirghizistan 7
OM - Oman 7
PR - Porto Rico 7
BN - Brunei Darussalam 6
GH - Ghana 6
MD - Moldavia 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
CW - ???statistics.table.value.countryCode.CW??? 5
MN - Mongolia 5
AO - Angola 4
EE - Estonia 4
GE - Georgia 4
Totale 66.200
Città #
Ann Arbor 6.775
Hong Kong 5.751
Woodbridge 2.667
Jacksonville 2.573
Singapore 2.503
Wilmington 2.311
San Jose 2.278
Chandler 2.163
Princeton 1.910
Milan 1.792
Houston 1.736
Ashburn 1.457
Dallas 1.185
Council Bluffs 1.160
Izmir 728
Dublin 620
Dong Ket 610
The Dalles 511
Nanjing 510
Rome 483
Andover 481
Lauterbourg 469
Beijing 443
Boardman 366
Memphis 360
Pellezzano 338
Ho Chi Minh City 295
Moscow 244
Düsseldorf 241
Naples 233
Santa Clara 227
Hanoi 207
Los Angeles 192
Hebei 178
Fairfield 171
Shenyang 167
Pune 165
Norwalk 164
Mestre 160
New York 160
Nanchang 157
Changsha 130
Jiaxing 118
Frankfurt am Main 113
Figino 105
São Paulo 103
Turin 99
Tokyo 97
Seattle 94
Washington 88
Salerno 81
Chicago 80
Tianjin 76
Atlanta 75
San Francisco 71
Redwood City 67
Brooklyn 64
Orem 64
Munich 63
Nuremberg 59
Des Moines 55
Da Nang 54
San Nicola la Strada 50
Warsaw 49
Baghdad 46
Montreal 46
Rio de Janeiro 46
San Diego 44
Boston 43
Toronto 40
Columbus 39
Phoenix 39
Amsterdam 37
Florence 36
Edinburgh 34
Helsinki 33
London 33
Philadelphia 33
Belo Horizonte 32
Cambridge 32
Denver 31
Chennai 30
Amman 28
Bologna 28
Dearborn 28
Dhaka 28
Miami 28
Tashkent 28
Nettuno 27
Haiphong 26
Mexico City 26
Hải Dương 25
San José 25
Jinan 24
Johannesburg 24
Buffalo 23
Catania 23
Guayaquil 23
Mumbai 23
Nairobi 23
Totale 48.130
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.279
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 662
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 545
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 480
Circadian rhythms and treatment implications in depression 471
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 451
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 442
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 380
Accuracy of self-assessment of real-life functioning in schizophrenia 372
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 359
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 356
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 334
Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels 319
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 268
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 246
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 242
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 229
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 226
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 222
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 218
Analysis of shared heritability in common disorders of the brain 215
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 213
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 199
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 194
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 193
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 188
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 187
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 183
An epidemiological study on eating disorders in two high schools in Naples 181
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders 175
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 172
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 171
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 171
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 168
Alterazioni neuroendocrine nella depressione stagionale 167
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 165
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 165
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 163
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 162
Evidence for opiate and estrogen interaction on neurohormonal secretion 162
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 161
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 161
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 159
Interhemispheric functional connectivity in anorexia and bulimia nervosa 159
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 158
The family of a patient with an eating disorder 158
Are antipsychotics useful in the treatment of anorexia nervosa? 157
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 156
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 155
Naloxone-induced decrease of plasma prolactin in healthy women 154
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 154
The treatment of unipolar depression by lithium salts 153
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 152
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 152
The circadian basis of mood disorders: Recent developments and treatment implications 151
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 151
Differences in Cortisol Awakening Response between Binge-Purging and Restrictive Patients with Anorexia Nervosa 151
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 149
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 149
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 149
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 149
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 148
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 148
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 148
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 148
Alexithymia and cortisol awakening response in people with eating disorders 148
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 147
Development and validation of the family coping questionnaire for eating disorders 147
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 147
Test alla d-fenfluramina e risposta al trattamento farmacologico nei pazienti con sindrome ossessivo-compulsiva 147
Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. 146
Psychobiology of eating disorders 146
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 145
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 145
Anoressia e Bulimia Nervosa - NOOS 145
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 145
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 144
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 144
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 143
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 142
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 141
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 141
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 141
Effects of acute and chronic haloperidol administration on the nocturnal activity of the rat pineal gland in vivo 140
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 140
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 140
PLASMA LEPTIN AND WEIGHT GAIN DURINO CLOZAPINE TREATMENT 140
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 140
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 140
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 138
How do relatives cope with eating disorders? Results from an Italian multicentre study 138
Subacute GHRH treatment restores GH response to GHRH in normal aging 137
2-[125]Iodomelatonin binding sites in the brain retina and Harderian gland of the green frog Rana esculenta 137
Psicobiologia dei disturbi del comportamento alimentare 137
Cortisol awakening response and depression in acute coronary syndrome patients 137
Acute trazodone administration decreases plasma cortisol levels in healthy subjects. 136
Valutazione dinamica dell’asse ipotalamo-ipofisi- surrene e del Sistema Nervoso Simpatico in risposta ad uno stress psicosociale nei Disturbi del Comportamento Alimentare 135
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 135
Leptin production in bulimia nervosa 135
INVESTIGATION OF NEUROACTIVE STEROIDS IN ANOREXIA AND BULIMIA NERVOSA 135
Totale 20.469
Categoria #
all - tutte 216.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.301 0 0 0 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/202622.629 1.384 2.949 3.484 666 2.189 1.243 3.609 717 1.043 1.895 663 2.787
2026/20274.418 1.341 686 2.307 84 0 0 0 0 0 0 0 0
Totale 67.485